“a nonsignificant trend”

The authors found no evidence that use of rATG was associated with PTLD, although there was a nonsignificant trend to more PTLD when rATG dose was 7.5 mg/kg or higher (1.55% vs. 0.50% with lower doses, P = 0.18) and the rate of PTLD was highest (2.62%) in heart transplant patients given rATG ≥7.5 mg/kg with no antiviral prophylaxis [ 70 ].

Arrhythmia showed a nonsignificant trend toward higher incidence in CTS+ ( P =0.18) (Table S11 ).

Although the neutrophil-derived enzyme MPO showed a nonsignificant trend toward higher levels in the DVT group ( P = .18), other established markers of inflammation, including hs-CRP, erythrocyte sedimentation rate, and total and differential white blood cell counts, were comparable between groups (all P > .05).

As shown in figure 1 , all questions showed a nonsignificant trend toward improvement (mean difference 1.33 [p = 0.18], 0.67 [p = 0.18], and 2.33 [p = 0.09], respectively).

This indicates a nonsignificant trend toward benefit with bempedoic acid (odds ratio [OR] 0.77, 95% confidence interval [CI] 0.52-1.13; P = 0.18).

There was also a nonsignificant trend for fewer median co-mutations in the LC compared with the SC group (1 versus 2, respectively, p = 0.1818).

VAT area declined by –12.31 (IQR, 61.53) in MAKE patients and by –1.11% (IQR, 50.63) in the stable group, showing a nonsignificant trend toward greater VAT loss in MAKE ( P = 0.1865; Figure 3 D).

This appeared as a nonsignificant trend when compared with the normal-hearing older adults, t (26) = 1.35, p = .187, but did reach significance when compared with the hearing-impaired older adults, t (26) = 2.39, p = .025.

There was a nonsignificant trend toward increased overexpression of HER2 in HGD lesions (5.3% vs. 0.0%, p = 0.187) ( Fig 2 ).

For incident AF (including POAF in perioperative trials), a nonsignificant trend toward reduction was observed (−0.198 ± 0.1498, Z = −1.319, 95% CI [−0.491, 0.096], p = 0.187; modest heterogeneity, I 2 ≈ 20%–30%). 3.3.

However, we observed a nonsignificant trend that energy restriction alone seemed to result in a loss of muscle mass ( P = 0.189, SMD: −0.23, 95% CI: −0.57, 0.11).

Untreated patients showed a nonsignificant trend towards reduced risk of death with overexpression of NTFs (HR=0.74, P =0.19).

Furthermore, there was a nonsignificant trend towards decreased mortality (OR 0.87, 95% CI 0.71–1.07; p=0.19) with PERTs.

Univariate meta-regression by reconstructive type (n = 7 studies) indicated a nonsignificant trend toward greater disparity in settings where implant-based reconstruction predominated ( P = .19).

The mean BPs at home or at the office did not differ when levels in current smokers ( n =17) were compared with nonsmokers, but there was a nonsignificant trend for a higher mean systolic SMOBP in nonsmokers than in smokers (smokers: 132.3±16 mmHg, nonsmokers: 138.6±19 mmHg, P =0.19).

In the PIRECNA registry there was only a nonsignificant trend for better outcome in the group with ablation conducted by an experienced operator [HR 0.52; 95% CI [0.19–1.41]; p=0.19], whereas in the multi-centre study by Aksu et al. there was virtually no difference between procedure-naïve operators and experienced ones. 28 , 62 These results may be explained by the fact that, from a technical point of view, CNA is not a difficult procedure for an operator who is experienced in performing complex ablation procedures, including ablation for AF.

In the adjusted logistic regression model for delirium, nurse-led management showed a nonsignificant trend toward reduced delirium (adjusted OR, 0.58; 95% CI, 0.26–1.30; P = 0.190) ( Table 5 ).

Quantitative analyses revealed that the levels of aggregated p62 inside the remaining ChAT + MNs at P120 differed significantly between non-SOD1 G93A -transgenic and SOD1 G93A mice, but not between SOD1 G93A mice and SOD1 G93A /Tbk1 +/− mice, despite a nonsignificant trend toward a reduction in SOD1 G93A /Tbk1 +/− mice (P = 0.19; Fig. 3 H ).

Prior CHT was associated with a nonsignificant trend towards worse OS (HR = 4.3, 95% CI: 0.5–38.2, p=0.19).

Our analysis of the OS differences stratified by DFI (Figure 4 ) showed a nonsignificant trend of shorter DFI leading to poorer prognosis ( P = 0.19).

Among patients with greater comorbidities (ACCI ≥6), hypofractionation was associated with a nonsignificant trend toward improved PFS (HR: 0.68, 95% CI: 0.38-1.21, p = 0.192).

The M classification (presence of distant metastasis) showed a nonsignificant trend toward poorer survival in metastatic cases ( P = 0.192).

For globulin levels, calculated as the difference between total protein and albumin, there was a nonsignificant trend toward higher concentrations in the Portal group ( β = +0.54 g/dL; 95% CI: −0.26 to 1.34; p = 0.193).

We noted a nonsignificant trend toward a greater reduction in medication use in the iTrack + phaco group (69%) with respect to the iTrack-alone group (36%) at 36 months ( p = 0.1955).

After IPTW adjustment, the IMT‐treated frail patients had a 3.1‐day (95% CI: 0.4–5.8, p = 0.024) reduction in mechanical ventilation duration with a nonsignificant trend toward lower 28‐day mortality ( p = 0.198).